Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Apr;89(4):411–418. doi: 10.1111/j.1349-7006.1998.tb00579.x

Novel Point Mutations and Allele Loss at the RET Locus in Sporadic Medullary Thyroid Carcinomas

Shinya Uchino 1,✉, Shiro Noguchi 1, Mitsuo Adachi 1, Mari Sato 1, Hiroyuki Yamashita 1, Shin Watanabe 1, Tsukasa Murakami 1, Masakatsu Toda 1, Nobuo Murakami 1, Hiroto Yamashita 2
PMCID: PMC5921821  PMID: 9617347

Abstract

Germline mutations in the RET proto‐oncogene have been shown to be the underlying cause of multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC). Some cases of sporadic medullary thyroid carcinoma (sporadic MTC) are reported to have specific codon 918, 883 and 768 mutations of the RET gene in tumor tissues. We examined RET gene mutations in 40 Japanese cases who had previously undergone surgery for sporadic MTC. DNA extracted from formalin‐fixed tumor tissues and corresponding normal thyroid tissues or peripheral blood leukocytes was analyzed for mutations of exon 10, 11, 13, 14 and 16 of the RET gene by DNA sequencing and by mutation‐specific restriction enzyme analysis. Germline RET point mutations were found in six of 40 cases (15%), cysteine residues at codon 618 in two, codon 634 in three and valine residue at codon 804 in one, and were newly identified as heritable MTC. Of the remaining 34 sporadic MTC cases, four (12%) had tumor‐specific RET point mutations. Two were found in exon 16; one case showed an ATG to ACG (Met to Thr) mutation at codon 918, and the other showed two point mutations, ATG to ACG (Met to Thr) at codon 918 and GCA to GTA (Ala to Val) at codon 919 with loss of the wild‐type allele, suggesting that both alleles at the RET locus were altered. The other two were found in exon 13; one case showed a CCG to TCG (Pro to Ser) mutation at codon 766 and the other showed a silent mutation, GTC to GTT (Val) at codon 778 with loss of the wild‐type allele. There was no association of sporadic mutations with recurrence or prognosis in patients with sporadic MTCs. The low rate of somatic RET mutation at codon 918 in our sporadic MTC suggests that as yet unknown factors may be involved. Genetic alterations in both alleles may have an important role in a small fraction of sporadic MTCs.

Keywords: Sporadic medullary thyroid carcinoma, RET gene, Point mutation, Allele loss, Multiple endocrine neoplasia

Full Text

The Full Text of this article is available as a PDF (340.4 KB).

REFERENCES

  • 1. ) Mulligan , L. M. and Ponder , B. A. J.Genetic basis of endocrine disease: multiple endocrine neoplasia type 2 . J. Clin. Endocrinol. Metab. , 80 , 1989 – 1995 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Goodfellow , P. J. and Wells , S. A. , Jr.RET gene and its implications for cancer . J. Natl. Cancer Inst. , 87 , 1515 – 1523 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Mulligan , L. M. , Kwok , J. B. J. , Healey , C. S. , Elsdon , M. J. , Eng , C. , Gardner , E. , Love , D. R. , Mole , S. E. , Moore , J. K. , Papi , L. , Ponder , M. A. , Telenius , H. , Tunnacliffe , A. and Ponder , B. A. J.Germ‐line mutations of the RET proto‐oncogene in multiple endocrine neoplasia type 2A . Nature , 363 , 458 – 460 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Donis‐Keller , H. , Dou , S. , Chi , D. , Carlson , K. M. , Toshima , K. , Lairmore , T. C. , Howe , J. R. , Moley , J. F. , Goodfellow , P. and Wells , S. A. , Jr.Mutations in the RET proto‐oncogene are associated with MEN 2A and FMTC . Hum. Mol. Genet. , 2 , 851 – 856 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Hofstra , R. M. W. , Landsvater , R. M. , Ceccherini , I. , Stulp , R. P. , Stelwagen , T. , Luo , Y. , Pasini , B. , Höppener , J. W. M. , van Amstel , H. K. P. , Romeo , G. , Lips , C. J. M. and Buys , C. H. C. M.A mutation in the RET proto‐oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma . Nature , 367 , 375 – 376 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Carlson , K. M. , Dou , S. , Chi , D. , Scavarda , N. , Toshima , K. , Jackson , C. E. , Wells , S. A. , Jr. , Goodfellow , P. J. and Donis‐Keller , H.Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B . Proc. Natl. Acad. Sci. USA , 91 , 1579 – 1583 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Eng , C. , Smith , D. P. , Mulligan , L. M. , Nagai , M. A. , Healey , C. S. , Ponder , M. A. , Gardner , E. , Scheumann , G. F. W. , Jackson , C. E. , Tunnacliffe , A. and Ponder , B. A. J.Point mutation within the tyrosine kinase domain of the RET proto‐oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours . Hum. Mol. Genet. , 3 , 237 – 241 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Eng , C. , Smith , D. P. , Mulligan , L. M. , Healey , C. S. , Zvelebil , M. J. , Stonehouse , T. J. , Ponder , M. A. , Jackson , C. E. , Waterfield , M. D. and Ponder , B. A. J.A novel point mutation in the tyrosine kinase domain of the RET proto‐oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC . Oncogene , 10 , 509 – 513 ( 1995. ). [PubMed] [Google Scholar]
  • 9. ) Bolino , A. , Schuffenecker , I. , Luo , Y. , Seri , M. , Silengo , M. , Tocco , T. , Chabrier , G. , Houdent , C. , Murat , A. , Schlumberger , M. , Tourniaire , J. , Lenoir , G. M. and Romeo , G.RET mutations in exons 13 and 14 of FMTC patients . Oncogene , 10 , 2415 – 2419 ( 1995. ). [PubMed] [Google Scholar]
  • 10. ) Komminoth , P. , Kunz , E. K. , Matias‐Guiu , X. , Hiort , O. , Christiansen , G. , Colomer , A. , Roth , J. and Heitz , P. U.Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas . Cancer , 76 , 479 – 489 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Eng , C. , Mulligan , L. M. , Smith , D. P. , Healey , C. S. , Frilling , A. , Raue , F. , Neumann , H. P. H. , Pfragner , R. , Behmel , A. , Lorenzo , M. J. , Stonehouse , T. J. , Ponder , M. A. and Ponder , B. A. J.Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma . Genes Chrom. Cancer , 12 , 209 – 212 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Fink , M. , Weinhäusel , A. , Niederle , B. and Haas , O. A.Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto‐oncogene . Int. J. Cancer , 69 , 312 – 316 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Blaugrund , J. E. , Johns , M. J. , Eby , Y. J. , Ball , D. W. , Baylin , S. B. , Hruban , R. H. and Sidransky , D.RET protooncogene mutations in inherited and sporadic medullary thyroid cancer . Hum. Mol. Genet. , 3 , 1895 – 1897 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Marsh , D. J. , Andrew , S. D. , Eng , C. , Learoyd , D. L. , Capes , A. G. , Pojer , R. , Richardson , A. L. , Houghton , C. , Mulligan , L. M. , Ponder , B. A. J. and Robinson , Germline B. G.and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma . Cancer Res. , 56 , 1241 – 1243 ( 1996. ). [PubMed] [Google Scholar]
  • 15. ) Zedenius , J. , Larsson , C. , Bergholm , U. , Bovee , J. , Svensson , A. , Hallengren , B. , Grimelius , L. , Backdahl , M. , Weber , G. and Wallin , G.Mutations of codon 918 in the RET proto‐oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas . J. Clin. Endocrinol. Metab. , 80 , 3088 – 3090 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Jhiang , S. M. , Fithian , L. , Weghorst , C. M. , Clark , O. H. , Falko , J. M. , O'Dorisio , T. M. and Mazzaferri , E. L.RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma . Thyroid , 6 , 115 – 121 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Romei , C. , Elisei , R. , Pinchera , A. , Ceccherini , I. , Molinaro , E. , Mancusi , F. , Martino , E. , Romeo , G. and Pacini , F.Somatic mutations of the RET protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence . J. Clin. Endocrinol. Metab. , 81 , 1619 – 1622 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Hofstra , R. M. W. , Stelwagen , T. , Stulp , R. P. , de Jong , D. , Hulsbeek , M. , Kamsteeg , E. J. , van den Berg , A. , Landsvater , R. M. , Vermey , A. , Molenaar , W. M. , Lips , C. J. M. and Buys , C. H. C. M.Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases . J. Clin. Endocrinol. Metab. , 81 , 2881 – 2884 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Ceccherini , I. , Pacini , B. , Pacini , F. , Gullo , M. , Bongarzone , I. , Romei , C. , Santamaria , G. , Matera , I. , Mondellini , P. , Scopsi , L. , Pinchera , A. , Pierotti , M. A. and Romeo , G.Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto‐oncogene . Oncogene , 14 , 2609 – 2612 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Alemi , M. , Lucas , S. D. , Sällström , J. F. , Bergholm , U. , Akerström , G. and Wilander , E.A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma . Oncogene , 14 , 2041 – 2045 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Uchino , S. , Tsuda , H. , Noguchi , M. , Yokota , J. , Terada , M. , Saito , T. , Kobayashi , M. , Sugimura , T. and Hirohashi , S.Frequent loss of heterozygosity at the DCC locus in gastric cancer . Cancer Res. , 52 , 3099 – 3102 ( 1992. ). [PubMed] [Google Scholar]
  • 22. ) Ceccherini , I. , Hofstra , R. M. W. , Luo , Y. , Stulp , R. P. , Barone , V. , Stelwagen , T. , Bocciardi , R. , Nijveen , H. , Bolino , A. , Seri , M. , Ronchetto , P. , Pasini , B. , Bozzano , M. , Buys , C. H. C. M. and Romeo , G.DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto‐oncogene . Oncogene , 9 , 3025 – 3029 ( 1994. ). [PubMed] [Google Scholar]
  • 23. ) Decker , R. A. , Peacock , M. L. , Borst , M. J. , Sweet , J. D. and Thompson , N. W.Progress in genetic screening of multiple endocrine neoplasia type 2A: is calcitonin testing obsolete ? Surgery , 118 , 257 – 263 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Wohlik , N. , Cote , G. J. , Bugalho , M. M. J. , Ordonez , N. , Evans , D. B. , Goepfert , H. , Khorana , S. , Schultz , P. , Richards , C. S. and Gagel , R. F.Relevance of RET proto‐oncogene mutations in sporadic medullary thyroid carcinoma . J. Clin. Endocrinol. Metab. , 81 , 3740 – 3745 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Kitamura , Y. , Goodfellow , P. J. , Shimizu , K. , Nagahama , M. , Ito , K. , Kitagawa , W. , Akasu , H. , Takami , H. , Tanaka , S. and Wells , S. A. , Jr.Novel germline RET proto‐oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC . Oncogene , 26 , 3103 – 3106 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Landsvater , R. M. , de Wit , M. J. , Zewald , R. A. , Hofstra , R. M. W. , Buys , C. H. C. M. , van Amstel , H. K. P. , Höppener , J. W. M. and Lips , C. J. M.Somatic mutations of the RET proto‐oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers . Cancer Res. , 56 , 4853 – 4855 ( 1996. ). [PubMed] [Google Scholar]
  • 27. ) Miyauchi , A. , Egawa , S. , Futami , H. , Kuma , K. , Obara , T. and Yamaguchi , K.A novel somatic mutation in the RET proto‐oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation . Jpn. J. Cancer Res. , 88 , 527 – 531 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Knudson , A. G.Antioncogenes and human cancer . Proc. Natl. Acad. Sci. USA , 90 , 10914 – 10921 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. ) Santoro , M. , Carlomagno , F. , Romano , A. , Bottaro , D. P. , Dathan , N. A. , Grieco , M. , Fusco , A. , Vecchio , G. , Matoskova , B. , Kraus , M. H. and Di Fiore , P. P.Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B . Science , 267 , 381 – 383 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Quadro , L. , Panariello , L. , Salvatore , D. , Carlomagno , F. , Del Prete , M. , Nunziata , V. , Colantuoni , V. , Di Giovanni , G. , Brandi , M. L. , Mannelli , M. , Gheri , R. , Verga , U. , Libroia , A. , Berger , N. , Fusco , A. , Grieco , M. and Santoro , M.Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A . J. Clin. Endocrinol. Metab. , 79 , 590 – 594 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Friend , S. H. , Horowitz , J. M. , Gerber , M. R. , Wang , X. F. , Bogenmann , E. , Li , F. P. and Weinberg , R. A.Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein . Proc. Natl. Acad. Sci. USA , 84 , 9059 – 9063 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Malkin , D. , Li , F. P. , Strong , L. C. , Fraumeni , J. F. , Nelson , C. E. , Kim , D. H. , Kassel , J. , Gryka , M. A. , Bis‐choff , F. Z. , Tainsky , M. A. and Friend , S. H.Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms . Science , 250 , 1233 – 1238 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Groden , J. , Thliveris , A. , Samowitz , W. , Carlson , M. , Gelbert , L. , Albertsen , H. , Joslyn , G. , Stevens , J. , Spirio , L. , Robertson , M. , Sargeant , L. , Krapcho , K. , Wolff , E. , Burt , R. , Hughes , J. P. , Warrington , J. , McPherson , J. , Wasmuth , J. , Paslier , D. L. , Abderrahim , H. , Cohen , D. , Leppert , M. and White , R.Identification and characterization of the familial adenomatous polyposis coli gene . Cell , 66 , 589 – 600 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Kinzler , K. W. , Nilbert , M. C. , Su , L. K. , Vogelstein , B. , Bryan , T. M. , Levy , D. B. , Smith , K. J. , Preisinger , A. C. , Hedge , P. , McKechnie , D. , Finniear , R. , Markham , A. , Groffen , J. , Boguski , M. S. , Altschul , S. F. , Horii , A. , Ando , H. , Miyoshi , Y. , Miki , Y. , Nishisho , I. and Nakamura , Y.Identification of FAP locus genes from chromosome 5q21 . Science , 253 , 661 – 665 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Mulligan , L. M. , Gardner , E. , Smith , B. A. , Mathew , C. G. P. and Ponder , A. J. P.Genetic events in tumor initiation and progression in multiple endocrine neoplasia type 2 . Genes Chrom. Cancer , 6 , 166 – 177 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Mathew , C. G. P. , Smith , B. A. , Thorpe , K. , Wong , Z. , Royle , N. J. , Jeffereys , A. J. and Ponder , B. A. J.Deletion of genes on chromosome 1 in endocrine neoplasia . Nature , 328 , 524 – 526 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Takai , S. , Tateishi , H. , Nishisho , I. , Miki , T. , Motomura , K. , Miyauchi , A. , Kato , M. , Ikeuchi , T. , Yamamoto , K. , Okazaki , M. , Yamamoto , M. , Honjo , T. , Kumahara , Y. and Mori , T.Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma . Jpn. J. Cancer Res. , 78 , 894 – 898 ( 1987. ). [PubMed] [Google Scholar]
  • 38. ) Yang , K. , Nguyen , C. V. , Castillo , S. G. and Samaan , N. A.Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type 2A . Anticancer Res. , 10 , 527 – 533 ( 1990. ). [PubMed] [Google Scholar]
  • 39. ) Yokogoshi , Y. , Yoshimoto , K. and Saito , S.Loss of heterozygosity on chromosomes 1 and 11 in sporadic pheochromocytomas. Jpn . J. Cancer Res. , 81 , 632 – 638 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. ) Khosla , S. , Patel , V. M. , Hay , I. D. , Schaid , D. J. , Grant , C. S. , van Heerden , J. A. and Thibodeau , S. N.Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas . J. Clin. Invest. , 87 , 1691 – 1699 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. ) Moley , J. F. , Brother , M. B. , Fong , C.‐T. , White , P. S. , Baylin , S. B. , Nelkin , B. , Wells , S. A. , Jr. and Brodeur , G. M.Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes . Cancer Res. , 52 , 770 – 774 ( 1992. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES